Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuronetics Q1 EPS $(0.21) Misses $(0.14) Estimate, Sales $31.98M Beat $29.07M Estimate

Author: Benzinga Newsdesk | May 06, 2025 06:12am
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 50 percent. This is a 22.22 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $31.98 million which beat the analyst consensus estimate of $29.07 million by 10.00 percent. This is a 83.59 percent increase over sales of $17.42 million the same period last year.

Posted In: STIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist